Processa Pharmaceuticals Rings the Nasdaq Stock Market Closing Bell
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Dr. David Young, President and CEO, rings the Closing Bell.